Scientists say the vitamin derivative pantethine showed “encouraging” results for reducing skin inflammation due to psoriasis.
From
To
TUESDAY, May 27, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Zoryve (roflumilast) topical foam 0.3 percent for…
